Follow
Yu Li (李钰)
Yu Li (李钰)
Synnovation Therapeutics
Verified email at fas.harvard.edu
Title
Cited by
Cited by
Year
Development of a RSK inhibitor as a novel therapy for triple-negative breast cancer
KA Ludwik, JP Campbell, M Li, Y Li, ZM Sandusky, L Pasic, ME Sowder, ...
Molecular cancer therapeutics 15 (11), 2598-2608, 2016
652016
Synthesis and structure–activity relationship study of 5a-carbasugar analogues of SL0101
M Li, Y Li, RM Mrozowski, ZM Sandusky, M Shan, X Song, B Wu, Q Zhang, ...
ACS Medicinal Chemistry Letters 6 (1), 95-99, 2015
322015
Stereoselective synthesis and evaluation of C6 ″-Substituted 5a-Carbasugar analogues of SL0101 as inhibitors of RSK1/2
M Li, Y Li, KA Ludwik, ZM Sandusky, DA Lannigan, GA O’Doherty
Organic letters 19 (9), 2410-2413, 2017
302017
RSK2 maintains adult estrogen homeostasis by inhibiting ERK1/2-mediated degradation of estrogen receptor alpha
KA Ludwik, ZM Sandusky, KM Stauffer, Y Li, KL Boyd, GA O’Doherty, ...
Cell reports 32 (3), 2020
132020
Regioselective Synthesis of a C-4′′ Carbamate, C-6′′ n-Pr Substituted Cyclitol Analogue of SL0101
Y Li, ZM Sandusky, R Vemula, Q Zhang, B Wu, S Fukuda, M Li, ...
Organic Letters 22 (4), 1448-1452, 2020
132020
The Alkyne Zipper Reaction in Asymmetric Synthesis
K Avocetien, Y Li, GA O'Doherty
Modern Alkyne Chemistry: Catalytic and Atom‐Economic Transformations, 365-394, 2014
112014
Synthesis and biological evaluation of 4′-substituted kaempfer-3-ols
S Kim, Y Li, L Lin, PR Sayasith, AT Tarr, EB Wright, S Yasmin, ...
The Journal of organic chemistry 85 (6), 4279-4288, 2020
102020
Synthesis of 6-(het) ary Xylocydine analogues and evaluating their inhibitory activities of CDK1 and CDK2 in vitro
C Xiao, C Sun, W Han, F Pan, Z Dan, Y Li, ZG Song, YH Jin
Bioorganic & medicinal chemistry 19 (23), 7100-7110, 2011
92011
The Affinity of RSK for Cylitol analogues of SL0101 is Critically Dependent on the B-Ring C-4′-Hydroxy
Y Li, P Seber, EB Wright, S Yasmin, DA Lannigan, GA O'Doherty
Chemical communications 56 (20), 3058-3060, 2020
82020
Identifying requirements for RSK2 specific inhibitors
EB Wright, S Fukuda, M Li, Y Li, GA O’Doherty, DA Lannigan
Journal of Enzyme Inhibition and Medicinal Chemistry 36 (1), 1798-1809, 2021
52021
Synthesis of a C-7 Pd-glycosyl-donor via the base promoted alkylative CO2 trapping with 2-acetylfuran
KR Francisco, Y Li, B Lindquist-Kleissler, J Zheng, Y Xing, GA O’Doherty
Journal of CO2 Utilization 54, 101774, 2021
32021
PI3Kα INHIBITORS
C Qi, L You, Z Fei, Y Li, H Zheng, Y Bai, J Pan, L Wu, W Yao
WO Patent WO/2023/205,680, 2023
2023
PARP1 INHIBITORS
J Pan, Y Bai, H Zheng, Y Li, J Yang, L Wu, W Yao
WO Patent WO/2023/122,140, 2023
2023
De novo synthesis of 5a-carbasugar analogs of SL0101
Y Li, M Li, G O'Doherty
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 250, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–14